Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × talazoparib × Gynecologic × Clear all

Phase

Phase 1 6 Phase 2 5 Phase 1/2 3 Phase 3 2 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Fallopian Tube Neoplasms 1

Interventions

olaparib 5 Specimen Handling 5 Paclitaxel 4 Magnetic Resonance Spectroscopy 4 Cyclophosphamide 4 Carboplatin 4 pembrolizumab 3 fludarabine 3 X-Rays 3 Taxes 3 Metformin 3 Letrozole 3 Biopsy 3 Aspirin 3 Tirzepatide 2 Radiotherapy 2 Propranolol 2 Platinum 2 Pafolacianine 2 Oncolytic Virotherapy 2 Hysterectomy 2 Hyperthermic Intraperitoneal Chemotherapy 2 Fluorodeoxyglucose F18 2 Fluorescein 2 Drug Therapy 2 Doxorubicin 2 Cytoreduction Surgical Procedures 2 Cisplatin 2 1,2-diaminocyclohexaneplatinum II citrate 2 trastuzumab biosimilar HLX02 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02316834 2022-02-24

POSITION

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Completed

Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡